Conjugation with nanodiamonds via hydrazone bond fundamentally alters intracellular distribution and activity of doxorubicin

An inventory of lysosomal ABC transporters

(2020) Gergely Szakacs et al.   FEBS LETTERS

Rational design of a minimalist nanoplatform to maximize immunotherapeutic efficacy: Four birds with one stone

(2020) Shiyao Zhou et al.   JOURNAL OF CONTROLLED RELEASE

Endoplasmic reticulum stress in doxorubicin-induced cardiotoxicity may be therapeutically targeted by natural and chemical compounds: A review

(2020) Fatemeh Yarmohammadi et al.   PHARMACOLOGICAL RESEARCH

Doxorubicin-polyglycerol-nanodiamond composites stimulate glioblastoma cell immunogenicity through activation of autophagy

(2019) Tong-Fei Li et al.   Acta Biomaterialia

Doxorubicin conjugated with nanodiamonds and in free form commit glioblastoma cells to heterodromous fates

(2019) Zhuo Chen et al.   Nanomedicine

Doxorubicin-polyglycerol-nanodiamond conjugate is a cytostatic agent that evades chemoresistance and reverses cancer-induced immunosuppression in triple-negative breast cancer

(2019) Shen-Jun Yuan et al.   JOURNAL OF NANOBIOTECHNOLOGY

Carboplatin chemoresistance is associated with CD11b+/Ly6C+ myeloid release and upregulation of TIGIT and LAG3/CD160 exhausted T cells

(2019) Doxakis Anestakis et al.   MOLECULAR IMMUNOLOGY

Cancer statistics, 2018

(2018) Rebecca L. Siegel et al.   CA-A CANCER JOURNAL FOR CLINICIANS

PEG and PEG-peptide based doxorubicin delivery systems containing hydrazone bond

(2018) Beste Balcı et al.   JOURNAL OF POLYMER RESEARCH

Monocyte-mediated chemotherapy drug delivery in glioblastoma

(2018) Chao Wang et al.   Nanomedicine

Doxorubicin-induced mitophagy and mitochondrial damage is associated with dysregulation of the PINK1/parkin pathway

(2018) Jian Yin et al.   TOXICOLOGY IN VITRO

Dendritic cell-mediated delivery of doxorubicin-polyglycerol-nanodiamond composites elicits enhanced anti-cancer immune response in glioblastoma

(2018) Tong-Fei Li et al.   BIOMATERIALS

Harnessing the cross-talk between tumor cells and tumor-associated macrophages with a nano-drug for modulation of glioblastoma immune microenvironment

(2017) Tong-Fei Li et al.   JOURNAL OF CONTROLLED RELEASE

Cell-Based Drug Delivery and Use of Nano-and Microcarriers for Cell Functionalization

(2017) Alexander S. Timin et al.   Advanced Healthcare Materials

Re-polarizing Myeloid-derived Suppressor Cells (MDSCs) with Cationic Polymers for Cancer Immunotherapy

(2016) Wei He et al.   Scientific Reports

Breast Cancer, Version 1.2016

(2015) William J. Gradishar et al.   Journal of the National Comprehensive Cancer Network

Phenotype, development, and biological function of myeloid-derived suppressor cells

(2015) Yang Zhao et al.   OncoImmunology

Polyglycerol-coated nanodiamond as a macrophage-evading platform for selective drug delivery in cancer cells

(2014) Li Zhao et al.   BIOMATERIALS

Endocytosis and exocytosis of nanoparticles in mammalian cells

(2014) Ji Ho Park et al.   International Journal of Nanomedicine

Chemotherapy-triggered cathepsin B release in myeloid-derived suppressor cells activates the Nlrp3 inflammasome and promotes tumor growth

(2012) Mélanie Bruchard et al.   NATURE MEDICINE

Amphiphilic multi-arm-block copolymer conjugated with doxorubicin via pH-sensitive hydrazone bond for tumor-targeted drug delivery

(2009) Mani Prabaharan et al.   BIOMATERIALS

The Role of ABC Transporters in Protecting Cells from Bilirubin Toxicity

(2009) C. Bellarosa et al.   CURRENT PHARMACEUTICAL DESIGN

ABC Transporters, Drug Resistance, and Cancer Stem Cells

(2009) Michael Dean   JOURNAL OF MAMMARY GLAND BIOLOGY AND NEOPLASIA

The DNA-damage response in human biology and disease

(2009) Stephen P. Jackson et al.   NATURE